Sequential Therapy with Gemcitabine and Carboplatin Followed by Paclitaxel as First Line Treatment for Advanced Urothelial Cancer

Παρόμοια τεκμήρια

• Phase II trial of combination nab-paclitaxel, carboplatin and gemcitabine in first line therapy of advanced urothelial carcinoma
  ανά: Alva, Ajjai, κ.ά.
  Έκδοση: (2013)
• A phase II feasibility study of carboplatin followed by sequential weekly paclitaxel and gemcitabine as first-line treatment for ovarian cancer
  ανά: Harries, M, κ.ά.
  Έκδοση: (2004)
• The combination of paclitaxel and carboplatin as second-line chemotherapy can be a preferred regimen for patients with urothelial carcinoma after the failure of gemcitabine and cisplatin chemotherapy
  ανά: Furubayashi, Nobuki, κ.ά.
  Έκδοση: (2017)
• Triple-Negative Breast Cancer in Lebanon: A Case Series
  ανά: Ghosn, Marwan, κ.ά.
  Έκδοση: (2011)
• A pilot study of gemcitabine and paclitaxel as third-line chemotherapy in metastatic urothelial carcinoma
  ανά: Naiki, Taku, κ.ά.
  Έκδοση: (2017)